Role of intravitreal injection of Bevacizumab as an adjuvant to the standard therapy of neovascular glaucoma
Nancy Ezz El-Regal Khamis Ahmed;
Abstract
Neovascular glaucoma is a serious disorder which occurs as a late complication of ischemic retinopathies. It is now well known that vascular endothelial growth factor (VEGF) plays a principle role in pathogenesis of neovascular glaucoma.
Recently
Recently
Other data
| Title | Role of intravitreal injection of Bevacizumab as an adjuvant to the standard therapy of neovascular glaucoma | Other Titles | دور حقن مادة البفاسيزوماب داخل الجسم الزجاجي للعين كعلاج مساعد للعلاج التقليدي في حالات المياه الزرقاء ذات الأوعية الدموية المستحدثة | Authors | Nancy Ezz El-Regal Khamis Ahmed | Keywords | Role of intravitreal injection of Bevacizumab as an adjuvant to the standard therapy of neovascular glaucoma | Issue Date | 2010 | Description | Neovascular glaucoma is a serious disorder which occurs as a late complication of ischemic retinopathies. It is now well known that vascular endothelial growth factor (VEGF) plays a principle role in pathogenesis of neovascular glaucoma. Recently |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| Binder1.pdf | 345.99 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.